Cargando…
External validation of prognostic models: what, why, how, when and where?
Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is nece...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857818/ https://www.ncbi.nlm.nih.gov/pubmed/33564405 http://dx.doi.org/10.1093/ckj/sfaa188 |
_version_ | 1783646518352281600 |
---|---|
author | Ramspek, Chava L Jager, Kitty J Dekker, Friedo W Zoccali, Carmine van Diepen, Merel |
author_facet | Ramspek, Chava L Jager, Kitty J Dekker, Friedo W Zoccali, Carmine van Diepen, Merel |
author_sort | Ramspek, Chava L |
collection | PubMed |
description | Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is necessary to determine a prediction model’s reproducibility and generalizability to new and different patients. Various methodological considerations are important when assessing or designing an external validation study. In this article, an overview is provided of these considerations, starting with what external validation is, what types of external validation can be distinguished and why such studies are a crucial step towards the clinical implementation of accurate prediction models. Statistical analyses and interpretation of external validation results are reviewed in an intuitive manner and considerations for selecting an appropriate existing prediction model and external validation population are discussed. This study enables clinicians and researchers to gain a deeper understanding of how to interpret model validation results and how to translate these results to their own patient population. |
format | Online Article Text |
id | pubmed-7857818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-78578182021-02-08 External validation of prognostic models: what, why, how, when and where? Ramspek, Chava L Jager, Kitty J Dekker, Friedo W Zoccali, Carmine van Diepen, Merel Clin Kidney J CKJ Reviews Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is necessary to determine a prediction model’s reproducibility and generalizability to new and different patients. Various methodological considerations are important when assessing or designing an external validation study. In this article, an overview is provided of these considerations, starting with what external validation is, what types of external validation can be distinguished and why such studies are a crucial step towards the clinical implementation of accurate prediction models. Statistical analyses and interpretation of external validation results are reviewed in an intuitive manner and considerations for selecting an appropriate existing prediction model and external validation population are discussed. This study enables clinicians and researchers to gain a deeper understanding of how to interpret model validation results and how to translate these results to their own patient population. Oxford University Press 2020-11-24 /pmc/articles/PMC7857818/ /pubmed/33564405 http://dx.doi.org/10.1093/ckj/sfaa188 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | CKJ Reviews Ramspek, Chava L Jager, Kitty J Dekker, Friedo W Zoccali, Carmine van Diepen, Merel External validation of prognostic models: what, why, how, when and where? |
title | External validation of prognostic models: what, why, how, when and where? |
title_full | External validation of prognostic models: what, why, how, when and where? |
title_fullStr | External validation of prognostic models: what, why, how, when and where? |
title_full_unstemmed | External validation of prognostic models: what, why, how, when and where? |
title_short | External validation of prognostic models: what, why, how, when and where? |
title_sort | external validation of prognostic models: what, why, how, when and where? |
topic | CKJ Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857818/ https://www.ncbi.nlm.nih.gov/pubmed/33564405 http://dx.doi.org/10.1093/ckj/sfaa188 |
work_keys_str_mv | AT ramspekchaval externalvalidationofprognosticmodelswhatwhyhowwhenandwhere AT jagerkittyj externalvalidationofprognosticmodelswhatwhyhowwhenandwhere AT dekkerfriedow externalvalidationofprognosticmodelswhatwhyhowwhenandwhere AT zoccalicarmine externalvalidationofprognosticmodelswhatwhyhowwhenandwhere AT vandiepenmerel externalvalidationofprognosticmodelswhatwhyhowwhenandwhere |